Medical Intelligence Quiz

Challenge Yourself, Build Your Knowledge

Eptinezumab for Migraine
Question 1 of 5

Which of these statements is most accurate about the use of eptinezumab for migraine compared with placebo?

All doses (10 mg-1000 mg) except 10 mg showed significant efficacy

The 1000-mg dosage was associated with a significant increase in adverse events

Lower ineffective doses slightly increased monthly headache days

Any dose of eptinezumab was associated with a significant increase in adverse events

Topics

Migraine

Quiz
Navigating the Complexities of Migraine Comorbidities Take Quiz
Ocular Measurements in Migraine Unveiled Take Quiz
Migraine Trigger Site Surgery Take Quiz
Epilepsy in Migraine Take Quiz
Eptinezumab for Migraine Take Quiz
Vestibular Migraine Key Clinical Aspects Take Quiz
Episodic Migraine Take Quiz
Pediatric Migraine Take Quiz
Diet and Migraine Take Quiz
Treatment for Episodic Migraine Take Quiz
Migraine Prophylaxis Take Quiz
Monoclonal antibody treatment for migraines Take Quiz
Hemiplegic Migraine Take Quiz
Migraine treatment scenarios Take Quiz
Pharmacotherapy for acute management of migraine Take Quiz
Evaluating symptoms in migraine differential diagnosis Take Quiz
Types of migraine surgical intervention Take Quiz
Quiz
Hormonal Effects on Migraine Take Quiz

More Challenges For You

Navigating the Complexities of Migraine Comorbidities
Take the Quiz
Migraine Differential Diagnosis
Solve the Puzzle
Transient monocular visual loss
Solve the Puzzle
Nausea and abdominal pain
Solve the Puzzle
Migraine Challenge Center